NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells.
J Immunother Cancer
; 11(8)2023 08.
Article
in En
| MEDLINE
| ID: mdl-37648262
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Interleukin-2
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2023
Document type:
Article
Affiliation country:
Sweden
Country of publication:
United kingdom